Mark Davison BSc

“Mark Davison is CEO of Blue Sphere Health Ltd (“Bluesphere”) a UK healthcare consultancy focusing on traceability, authentication and patient engagement. He has worked in the drug industry for 26 years including time with GlaxoSmithKline, several contract research organisations, two biotechnology companies and two traceability vendors. At Bluesphere, Mark works with a number of global drug companies and public sector organisations on serialisation and traceability. Mark is a frequent speaker at industry conferences and is currently writing the second edition of “Pharmaceutical Anti-Counterfeiting".